A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
about
Combination pharmacotherapy for the treatment of neuropathic pain in adultsKetamine for pain in adults and children with cancer: a systematic review and synthesis of the literatureVincristine-induced peripheral neuropathy in pediatric cancer patientsA phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivorsPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Noradrenergic reuptake inhibition in the treatment of pain.Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trialTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Therapeutic strategies for cancer treatment related peripheral neuropathies.Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Breast cancer survivorship issues.Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathyPlatinum-induced neurotoxicity and preventive strategies: past, present, and futureThe relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP studyNovel Treatment of Radicular Pain With a Multi-Mechanistic Combination Topical Agent: A Case Series and Literature ReviewRandomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapyRandomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsNational Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance).Bottlenecks in the development of topical analgesics: molecule, formulation, dose-finding, and phase III design.High doses of topical amitriptyline in neuropathic pain: two cases and literature review.Chemotherapy-induced peripheral neuropathy: prevention and treatment.Neuropathic pain and pharmacological treatment.Methodological considerations in the design and implementation of clinical trials.Cancer treatment-related neuropathic pain syndromes--epidemiology and treatment: an update.Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.Drug combinations in the treatment of neuropathic pain.Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Topical analgesics for neuropathic pain in the elderly: current and future prospects.Treatment of painful diabetic peripheral neuropathy.Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications.Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.Systematic review of topical amitriptyline for the treatment of neuropathic pain.Chemotherapy-induced peripheral neuropathy: a literature review.Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials.
P2860
Q24202050-961F4555-10AB-4D38-9E87-1F1D02AD87A9Q27007770-7D78A970-0E70-4B89-B7FC-2E45A2A262BCQ28078232-0CEF33B3-3846-4A60-9F4E-8392CBAB05A9Q33693343-8FF5A909-94C4-4BB6-B3B5-89F05887EBBFQ33744706-A45F53ED-B307-49CD-95D1-50A1350F49D1Q34304397-7ECCD3C6-B803-4AEA-9C4C-E394B23B721BQ34336573-9A7442E7-743B-48C4-BF5D-742A58EFD5F3Q34376548-0BB0A8DC-075E-4FC2-AE31-95A8646BBD84Q34433406-471EA8E7-BAA4-430E-86C6-0DAF96D1C2A9Q34458581-05C90FAB-BC31-4B76-B5C7-3244495DCC72Q34895561-EC030D40-D2EA-48E5-A86B-1831CABA20F7Q35248222-6622A061-B9E8-49CC-8ABB-00235C8FDE4CQ35248891-8F656E8A-0FD2-44E0-8260-FEE53F356E4FQ35345734-C55712F7-6F65-45B9-9EF0-AA51E5F95CF6Q35898601-DE5A61E7-32AB-48E0-AEF8-48D890F8E5ADQ36226275-C38C444A-E049-46A6-9DEB-D1A6E12F03ABQ36551631-5CD36701-28A4-411D-B0C2-837E70BF7EE6Q36893328-10DEAD6B-EFC9-4BDC-A162-A4DA4A42F2C3Q36950068-7A193C89-6459-45C8-98E2-B6AEACC29859Q36977059-CDDE2123-5160-477F-AC1A-A30C991F2CDAQ37046151-FF011FAB-553C-4362-9804-14392FCE1D59Q37170634-36714C6E-770D-4A41-8D5B-73034A4B0383Q37364316-7F4722DE-6FA2-47BE-A409-33DB1E830CB6Q37662241-6E22B366-37B8-49E4-8974-9D8950A3C46AQ37720689-3CB1B520-CC8C-4A2F-8B71-840355FBC5ABQ37890042-509F9E36-8748-47AD-AD66-C0F4349DFFCFQ37911252-37977AE3-ECB6-46E4-9C36-D6DA2F49FBD4Q38113229-A8106979-B930-4816-98FA-1490D49A2AF4Q38190172-A1C0C054-BC8F-452A-8A0F-3CA533CD7C90Q38252761-5BB7BFC0-8C3E-4DB6-9937-0B7B3E5172E0Q38254351-34267CE5-CD03-4CCA-9754-B91C39FCB2DAQ38258294-5560237B-ACD7-42F8-A102-D9C9901F036FQ38264622-765EF8B7-D3B5-4ADB-B198-8209FE27A903Q38265422-BD541261-34A6-40BE-AC69-EBD90BA38FBFQ38329620-DA7730BA-315C-40C8-A92E-AB3E4AD9D8EAQ38335767-A40ACC3E-3983-4DB6-801A-3EE15B3297B6Q38522262-242C4736-E952-4FC7-8C44-A6DBDA403C6FQ38523015-04FD46F1-AB3D-4ABA-912A-03575C159B5FQ38694811-61C09069-AAF0-4ECB-B2A2-B8F059CAA0C0Q38716340-FFDE495D-0446-41F7-AAF1-E0B98902679A
P2860
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@ast
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@en
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@nl
type
label
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@ast
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@en
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@nl
prefLabel
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@ast
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@en
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@nl
P2093
P2860
P1476
A double-blind, placebo-contro ...... neuropathy: NCCTG trial N06CA.
@en
P2093
Bassam I Mattar
Bradley Christensen
Charles L Loprinzi
Debra L Barton
Edward J Wos
James Dewitt Bearden
John W Kugler
Kay L Hoff
Keith S Lanier
Kendrith M Rowland
P2860
P2888
P304
P356
10.1007/S00520-010-0911-0
P577
2010-05-25T00:00:00Z